Partial Meniscus Replacement with a Collagen-Hyaluronan Infused Three-Dimensional Printed Polymeric Scaffold

Area of Science:

• Biomaterials science
• Orthopedic surgery
• Regenerative medicine

Background:

• The Collagen Meniscus Implant (CMI) is the only FDA-approved partial meniscus scaffold but lacks broad insurance reimbursement.
• There is a clinical need for meniscus scaffolds with superior mechanical properties and efficacy.
• Partial meniscectomy increases the risk of osteoarthritis, highlighting the need for effective meniscus repair strategies.

Purpose of the Study:

• To evaluate the feasibility of a novel acellular, off-the-shelf scaffold for meniscus regeneration in an animal model.
• To assess the potential of this scaffold to restore knee biomechanics after partial meniscectomy.
• To provide a foundation for future studies investigating osteoarthritis prevention following meniscus injury.

Main Methods:

• A novel acellular scaffold was developed.
• The scaffold's ability to restore knee biomechanics following partial meniscectomy was assessed in an animal model.
• Feasibility of the scaffold implantation and its integration was evaluated.

Main Results:

• The novel acellular scaffold demonstrated the ability to restore knee biomechanics after partial meniscectomy in the animal model.
• Preliminary data suggests the scaffold is a feasible option for meniscus repair.
• Further investigation is warranted to confirm efficacy and long-term outcomes.

Conclusions:

• This first-in-animal study presents promising feasibility data for a novel acellular meniscus scaffold.
• The scaffold has the potential to restore knee biomechanics and may reduce the risk of post-meniscectomy osteoarthritis.
• Further research is needed to validate these findings and explore clinical applications.